Bernzott Capital Advisors’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
Bernzott Capital Advisors's HALO Position: Q2 2026 in Review
Bernzott Capital Advisors increased its Halozyme (HALO) stake by 12% in Q2 2026, buying an estimated $552K and bringing the position to 76,376 shares worth $5.98M. The position accounts for 2.39% of the portfolio, ranked #16.
Bernzott Capital Advisors first reported a position in HALO in Q1 2022 and has held it in 17 quarters since. The position peaked at $25.3M in Q4 2022. 672 funds tracked by Wall St. Rank hold HALO as of Q2 2026.
- Bernzott Capital Advisors held 76,376 shares of Halozyme worth $5.98M as of Q2 2026.
- Bernzott Capital Advisors bought 8,099 Halozyme shares in Q2 2026, an estimated $552K.
- Halozyme made up 2.39% of Bernzott Capital Advisors's portfolio in Q2 2026, its #16 holding.
- Bernzott Capital Advisors first reported a position in Halozyme in Q1 2022 and has held it in 17 quarters since.
- Bernzott Capital Advisors's Halozyme position peaked at $25.3M in Q4 2022.
- 672 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.
Based on Bernzott Capital Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.